nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—TAAR1—neck—thyroid cancer	0.101	0.181	CbGeAlD
Methamphetamine—TAAR1—thyroid gland—thyroid cancer	0.0481	0.086	CbGeAlD
Methamphetamine—SLC18A1—head—thyroid cancer	0.0454	0.0811	CbGeAlD
Methamphetamine—SLC18A1—lymph node—thyroid cancer	0.0318	0.0568	CbGeAlD
Methamphetamine—MAOA—neck—thyroid cancer	0.0193	0.0345	CbGeAlD
Methamphetamine—SLC22A3—saliva-secreting gland—thyroid cancer	0.0191	0.0341	CbGeAlD
Methamphetamine—MAOB—saliva-secreting gland—thyroid cancer	0.0177	0.0315	CbGeAlD
Methamphetamine—SLC18A2—thyroid gland—thyroid cancer	0.0163	0.0292	CbGeAlD
Methamphetamine—MAOA—saliva-secreting gland—thyroid cancer	0.0151	0.0269	CbGeAlD
Methamphetamine—SLC18A2—head—thyroid cancer	0.0145	0.0259	CbGeAlD
Methamphetamine—SLC22A5—saliva-secreting gland—thyroid cancer	0.0139	0.0248	CbGeAlD
Methamphetamine—SLC22A3—thyroid gland—thyroid cancer	0.0116	0.0208	CbGeAlD
Methamphetamine—MAOA—trachea—thyroid cancer	0.0116	0.0208	CbGeAlD
Methamphetamine—ADRA2C—trachea—thyroid cancer	0.0112	0.02	CbGeAlD
Methamphetamine—SLC6A3—head—thyroid cancer	0.011	0.0196	CbGeAlD
Methamphetamine—MAOB—thyroid gland—thyroid cancer	0.0108	0.0192	CbGeAlD
Methamphetamine—SLC22A5—trachea—thyroid cancer	0.0107	0.0191	CbGeAlD
Methamphetamine—SLC22A3—head—thyroid cancer	0.0103	0.0185	CbGeAlD
Methamphetamine—SLC18A2—lymph node—thyroid cancer	0.0102	0.0181	CbGeAlD
Methamphetamine—SLC6A4—head—thyroid cancer	0.0101	0.018	CbGeAlD
Methamphetamine—MAOB—head—thyroid cancer	0.00956	0.0171	CbGeAlD
Methamphetamine—MAOA—thyroid gland—thyroid cancer	0.00919	0.0164	CbGeAlD
Methamphetamine—ADRA2A—trachea—thyroid cancer	0.00891	0.0159	CbGeAlD
Methamphetamine—SLC6A2—head—thyroid cancer	0.00885	0.0158	CbGeAlD
Methamphetamine—SLC22A5—thyroid gland—thyroid cancer	0.00847	0.0151	CbGeAlD
Methamphetamine—MAOA—head—thyroid cancer	0.00815	0.0146	CbGeAlD
Methamphetamine—ADRA2C—head—thyroid cancer	0.00784	0.014	CbGeAlD
Methamphetamine—SLC22A3—lymph node—thyroid cancer	0.00723	0.0129	CbGeAlD
Methamphetamine—ADRA2A—thyroid gland—thyroid cancer	0.00705	0.0126	CbGeAlD
Methamphetamine—MAOB—lymph node—thyroid cancer	0.00669	0.012	CbGeAlD
Methamphetamine—ADRA2A—head—thyroid cancer	0.00626	0.0112	CbGeAlD
Methamphetamine—SLC6A2—lymph node—thyroid cancer	0.0062	0.0111	CbGeAlD
Methamphetamine—MAOA—lymph node—thyroid cancer	0.00571	0.0102	CbGeAlD
Methamphetamine—ADRA2C—lymph node—thyroid cancer	0.00549	0.00981	CbGeAlD
Methamphetamine—SLC22A5—lymph node—thyroid cancer	0.00526	0.0094	CbGeAlD
Methamphetamine—CYP2D6—head—thyroid cancer	0.00485	0.00866	CbGeAlD
Methamphetamine—ADRA2A—lymph node—thyroid cancer	0.00438	0.00783	CbGeAlD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000883	0.002	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—MINPP1—thyroid cancer	0.000876	0.00199	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000868	0.00197	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CHST14—thyroid cancer	0.000851	0.00193	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000849	0.00193	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000846	0.00192	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—PRKAR1A—thyroid cancer	0.000842	0.00191	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet Aggregation (Plug Formation)—AKT1—thyroid cancer	0.000826	0.00188	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000825	0.00187	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—SST—thyroid cancer	0.00082	0.00186	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—PTCH1—thyroid cancer	0.000814	0.00185	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CALCB—thyroid cancer	0.000805	0.00183	CbGpPWpGaD
Methamphetamine—MAOA—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.00079	0.00179	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CALCA—thyroid cancer	0.000789	0.00179	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—PRKAR1A—thyroid cancer	0.000786	0.00179	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000782	0.00178	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000782	0.00178	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000769	0.00175	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—PTCH1—thyroid cancer	0.00076	0.00173	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—NDUFA13—thyroid cancer	0.000745	0.00169	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—SST—thyroid cancer	0.000744	0.00169	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000741	0.00168	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000734	0.00167	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—TSHR—thyroid cancer	0.000726	0.00165	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—CALCA—thyroid cancer	0.000716	0.00163	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CDK1—thyroid cancer	0.000714	0.00162	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000713	0.00162	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—MINPP1—thyroid cancer	0.000711	0.00162	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000711	0.00161	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CHST14—thyroid cancer	0.0007	0.00159	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—SST—thyroid cancer	0.000695	0.00158	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—HPGD—thyroid cancer	0.000686	0.00156	CbGpPWpGaD
Methamphetamine—SLC6A4—Circadian rythm related genes—PTEN—thyroid cancer	0.000676	0.00154	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—CALCA—thyroid cancer	0.000669	0.00152	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000661	0.0015	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—PRKAR1A—thyroid cancer	0.000639	0.00145	CbGpPWpGaD
Methamphetamine—CYP2D6—Biological oxidations—RXRA—thyroid cancer	0.000631	0.00143	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—TPR—thyroid cancer	0.000628	0.00143	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CALCB—thyroid cancer	0.000627	0.00142	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PRKAR1A—thyroid cancer	0.000618	0.0014	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—PTCH1—thyroid cancer	0.000617	0.0014	CbGpPWpGaD
Methamphetamine—MAOA—Neuronal System—BRAF—thyroid cancer	0.000605	0.00137	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—NDUFA13—thyroid cancer	0.000605	0.00137	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TRIM33—thyroid cancer	0.000594	0.00135	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CALCB—thyroid cancer	0.000585	0.00133	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000585	0.00133	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—NRG1—thyroid cancer	0.000573	0.0013	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CHST14—thyroid cancer	0.000569	0.00129	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000566	0.00129	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—SST—thyroid cancer	0.000565	0.00128	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—HPGD—thyroid cancer	0.000564	0.00128	CbGpPWpGaD
Methamphetamine—SLC6A3—Neuronal System—BRAF—thyroid cancer	0.000562	0.00128	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—IFNA2—thyroid cancer	0.000558	0.00127	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000555	0.00126	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TRIM33—thyroid cancer	0.000555	0.00126	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—CALCA—thyroid cancer	0.000543	0.00123	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—TSHR—thyroid cancer	0.000541	0.00123	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—TPR—thyroid cancer	0.000531	0.00121	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PRKAR1A—thyroid cancer	0.000523	0.00119	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—IFNA2—thyroid cancer	0.000521	0.00118	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TERT—thyroid cancer	0.000515	0.00117	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—TSHR—thyroid cancer	0.000505	0.00115	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HIF1A—thyroid cancer	0.000492	0.00112	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000492	0.00112	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—TSHR—thyroid cancer	0.000491	0.00112	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000483	0.0011	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CALCB—thyroid cancer	0.000475	0.00108	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—SLC5A5—thyroid cancer	0.00047	0.00107	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MINPP1—thyroid cancer	0.000463	0.00105	CbGpPWpGaD
Methamphetamine—SLC6A4—Circadian rythm related genes—TP53—thyroid cancer	0.000461	0.00105	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—TSHR—thyroid cancer	0.000459	0.00104	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—HPGD—thyroid cancer	0.000458	0.00104	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000451	0.00102	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TRIM33—thyroid cancer	0.000451	0.00102	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—NRAS—thyroid cancer	0.000434	0.000985	CbGpPWpGaD
Methamphetamine—SLC18A2—Neuronal System—HRAS—thyroid cancer	0.000434	0.000985	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IFNA2—thyroid cancer	0.000423	0.000961	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—SST—thyroid cancer	0.000421	0.000955	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PTCH1—thyroid cancer	0.000418	0.000948	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—TSHR—thyroid cancer	0.00041	0.000932	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—BRAF—thyroid cancer	0.000408	0.000926	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CALCA—thyroid cancer	0.000405	0.000919	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—SLC5A5—thyroid cancer	0.000398	0.000903	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TCF7L1—thyroid cancer	0.000396	0.0009	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—RXRA—thyroid cancer	0.000395	0.000897	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	0.000394	0.000895	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—TPR—thyroid cancer	0.000394	0.000895	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—SST—thyroid cancer	0.000393	0.000892	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PTCH1—thyroid cancer	0.00039	0.000886	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PRKAR1A—thyroid cancer	0.000388	0.00088	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—SST—thyroid cancer	0.000382	0.000867	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CALCA—thyroid cancer	0.000378	0.000859	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—KRAS—thyroid cancer	0.000373	0.000848	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—TSHR—thyroid cancer	0.000373	0.000846	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CHST14—thyroid cancer	0.00037	0.000841	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TCF7L1—thyroid cancer	0.00037	0.000841	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CALCA—thyroid cancer	0.000368	0.000835	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000367	0.000833	CbGpPWpGaD
Methamphetamine—MAOA—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000363	0.000825	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—SST—thyroid cancer	0.000357	0.00081	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CALCA—thyroid cancer	0.000343	0.00078	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000337	0.000766	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—RXRA—thyroid cancer	0.000334	0.000759	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CDK1—thyroid cancer	0.000333	0.000756	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—TPR—thyroid cancer	0.000324	0.000736	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—SST—thyroid cancer	0.000319	0.000725	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PRKAR1A—thyroid cancer	0.000319	0.000724	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—HRAS—thyroid cancer	0.000317	0.000721	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PTCH1—thyroid cancer	0.000317	0.00072	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CDK1—thyroid cancer	0.000311	0.000706	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—AKT1—thyroid cancer	0.000309	0.000701	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CALCA—thyroid cancer	0.000307	0.000698	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TCF7L1—thyroid cancer	0.000301	0.000683	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—HPGD—thyroid cancer	0.000299	0.000678	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CCND1—thyroid cancer	0.000298	0.000676	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—SLC5A5—thyroid cancer	0.000295	0.00067	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TSHR—thyroid cancer	0.00029	0.000659	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—SST—thyroid cancer	0.00029	0.000658	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—PTEN—thyroid cancer	0.000287	0.000652	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PRKAR1A—thyroid cancer	0.000285	0.000648	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—AKT1—thyroid cancer	0.00028	0.000636	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CALCA—thyroid cancer	0.000279	0.000633	CbGpPWpGaD
Methamphetamine—MAOA—Neuronal System—HRAS—thyroid cancer	0.000278	0.000632	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MEN1—thyroid cancer	0.000273	0.000619	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TSHR—thyroid cancer	0.000271	0.000615	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PRKAR1A—thyroid cancer	0.000267	0.000605	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—TPR—thyroid cancer	0.000263	0.000598	CbGpPWpGaD
Methamphetamine—ADRA2B—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.000261	0.000592	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PRKAR1A—thyroid cancer	0.000259	0.000588	CbGpPWpGaD
Methamphetamine—SLC6A3—Neuronal System—HRAS—thyroid cancer	0.000259	0.000587	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—NRAS—thyroid cancer	0.000256	0.000582	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MEN1—thyroid cancer	0.000255	0.000579	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CDK1—thyroid cancer	0.000252	0.000573	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PPARG—thyroid cancer	0.000249	0.000566	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—RXRA—thyroid cancer	0.000248	0.000563	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PTCH1—thyroid cancer	0.000247	0.00056	CbGpPWpGaD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.000243	0.000553	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—SLC5A5—thyroid cancer	0.000243	0.000551	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PTCH1—thyroid cancer	0.00023	0.000523	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SST—thyroid cancer	0.000226	0.000512	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—KRAS—thyroid cancer	0.000221	0.000501	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TSHR—thyroid cancer	0.00022	0.0005	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CALCA—thyroid cancer	0.000217	0.000493	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRKAR1A—thyroid cancer	0.000217	0.000492	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PPARG—thyroid cancer	0.000211	0.000479	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SST—thyroid cancer	0.000211	0.000479	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—NRAS—thyroid cancer	0.000208	0.000472	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MEN1—thyroid cancer	0.000207	0.00047	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—RXRA—thyroid cancer	0.000204	0.000463	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CALCA—thyroid cancer	0.000203	0.000461	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.000198	0.000449	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—SLC5A5—thyroid cancer	0.000197	0.000448	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CDK1—thyroid cancer	0.000197	0.000446	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTGS2—thyroid cancer	0.000196	0.000445	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TP53—thyroid cancer	0.000196	0.000445	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—NRAS—thyroid cancer	0.000194	0.000441	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HRAS—thyroid cancer	0.000187	0.000426	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTCH1—thyroid cancer	0.000187	0.000425	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CDK1—thyroid cancer	0.000184	0.000417	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—KRAS—thyroid cancer	0.000179	0.000407	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TPR—thyroid cancer	0.000172	0.00039	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SST—thyroid cancer	0.000171	0.000389	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTEN—thyroid cancer	0.000171	0.000388	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	0.000169	0.000383	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—KRAS—thyroid cancer	0.000167	0.00038	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTGS2—thyroid cancer	0.000166	0.000377	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—RXRA—thyroid cancer	0.000166	0.000376	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—AKT1—thyroid cancer	0.000166	0.000376	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CALCA—thyroid cancer	0.000165	0.000374	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TP53—thyroid cancer	0.000159	0.000361	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—NRAS—thyroid cancer	0.000158	0.000358	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NRG1—thyroid cancer	0.000158	0.000358	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PPARG—thyroid cancer	0.000156	0.000355	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—HRAS—thyroid cancer	0.000152	0.000346	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CDK1—thyroid cancer	0.000149	0.000339	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TP53—thyroid cancer	0.000149	0.000338	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NRG1—thyroid cancer	0.000147	0.000335	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTEN—thyroid cancer	0.000145	0.000329	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—HRAS—thyroid cancer	0.000142	0.000323	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TERT—thyroid cancer	0.000142	0.000322	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—KRAS—thyroid cancer	0.000136	0.000308	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HIF1A—thyroid cancer	0.000135	0.000308	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—AKT1—thyroid cancer	0.000134	0.000305	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TERT—thyroid cancer	0.000132	0.000301	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PPARG—thyroid cancer	0.000129	0.000292	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	0.000128	0.000292	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HIF1A—thyroid cancer	0.000127	0.000287	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—AKT1—thyroid cancer	0.000125	0.000285	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS2—thyroid cancer	0.000123	0.00028	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TP53—thyroid cancer	0.000121	0.000274	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	0.00012	0.000272	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—NRAS—thyroid cancer	0.000119	0.000271	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—HRAS—thyroid cancer	0.000115	0.000262	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—BRAF—thyroid cancer	0.000112	0.000255	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—NRAS—thyroid cancer	0.000111	0.000253	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—RXRA—thyroid cancer	0.000108	0.000245	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TERT—thyroid cancer	0.000107	0.000244	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTEN—thyroid cancer	0.000107	0.000244	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—BRAF—thyroid cancer	0.000105	0.000238	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PPARG—thyroid cancer	0.000105	0.000237	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	0.000103	0.000233	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	0.000103	0.000233	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—AKT1—thyroid cancer	0.000102	0.000232	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS2—thyroid cancer	0.000101	0.00023	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—AKT1—thyroid cancer	9.86e-05	0.000224	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—KRAS—thyroid cancer	9.6e-05	0.000218	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	9.06e-05	0.000206	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTEN—thyroid cancer	8.83e-05	0.000201	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	8.73e-05	0.000198	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	8.51e-05	0.000193	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	8.49e-05	0.000193	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—AKT1—thyroid cancer	8.34e-05	0.000189	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS2—thyroid cancer	8.22e-05	0.000187	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	8.19e-05	0.000186	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HRAS—thyroid cancer	8.16e-05	0.000185	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—AKT1—thyroid cancer	7.93e-05	0.00018	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	7.9e-05	0.000179	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	7.79e-05	0.000177	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	7.71e-05	0.000175	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCND1—thyroid cancer	7.65e-05	0.000174	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PTEN—thyroid cancer	7.38e-05	0.000168	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—AKT1—thyroid cancer	7.2e-05	0.000164	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTEN—thyroid cancer	7.17e-05	0.000163	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	7.05e-05	0.00016	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPARG—thyroid cancer	6.81e-05	0.000155	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	6.63e-05	0.00015	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NRAS—thyroid cancer	6.59e-05	0.00015	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	6.44e-05	0.000146	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	6.21e-05	0.000141	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—AKT1—thyroid cancer	6.19e-05	0.00014	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	6.07e-05	0.000138	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	6e-05	0.000136	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	5.85e-05	0.000133	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—KRAS—thyroid cancer	5.67e-05	0.000129	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TP53—thyroid cancer	5.39e-05	0.000123	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS2—thyroid cancer	5.36e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	5.35e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	5.16e-05	0.000117	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—AKT1—thyroid cancer	5.09e-05	0.000116	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TP53—thyroid cancer	5.04e-05	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HRAS—thyroid cancer	4.82e-05	0.000109	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTEN—thyroid cancer	4.67e-05	0.000106	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	4.6e-05	0.000105	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	4.55e-05	0.000103	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AKT1—thyroid cancer	4.25e-05	9.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—AKT1—thyroid cancer	4.13e-05	9.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	4.09e-05	9.29e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	3.91e-05	8.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	3.46e-05	7.85e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—AKT1—thyroid cancer	2.69e-05	6.12e-05	CbGpPWpGaD
